Journal Publications

← Back to Publications

Peer-reviewed journal publications. See preprints for manuscripts shared before journal publication.

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial

The Lancet Respiratory Medicine · 2026

Infectious diseases

Citation for Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial

Van Rie, A., Conceição, E.C., Ndebele, F., Wells, F., Paulse, A., Mekonnen, E.G., Ngarega, M., Trang, T.P.H., Bohlela, S., Sibeko, Z., Segwaba, P., Verboven, L., Heupink, T.H., Fuertes, M.D.D., Rennie, V., Dippenaar, A., Rigouts, L., Setlhare, L., Ogunbayo, A.E., VanderSpoel Van Dyk, A., Conradie, F., Maartens, G., Potgieter, S., Black, J., Fanampe, B., Abrams, S., Churchyard, G., Warren, R., & Charalambous, S. (2026) "Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial." The Lancet Respiratory Medicine. 14(6), 521–532.

Population-level associations in the spread of co-circulating respiratory viruses: A multi-method statistical investigation using incidence data

EPIDEMICS · 2026

Citation for Population-level associations in the spread of co-circulating respiratory viruses: A multi-method statistical investigation using incidence data

Barth, Nadine; Carstens, Gesa; Kozanli, Eva; Han , Wanda; Hermans, Lisa; Paolotti, Daniela; Abrams, Steven; Molenberghs, Geert; Hens, Niel; Faes, Christel; Eggink, Dirk; Van Hoek, Albert Jan; Torneri, Andrea. (2026). Population-level associations in the spread of co-circulating respiratory viruses: A multi-method statistical investigation using incidence data. EPIDEMICS.

Nonparametric estimation of the quantiles of the conditional residual lifetime distribution

Journal of Statistical Planning and Inference · 2026

Statistical methods

Citation for Nonparametric estimation of the quantiles of the conditional residual lifetime distribution

Abrams, S., Janssen, P., & Veraverbeke, N. (2026) "Nonparametric estimation of the quantiles of the conditional residual lifetime distribution." Journal of Statistical Planning and Inference. 243, 106373.

Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium

Eurosurveillance · 2026

Infectious diseases

Citation for Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium

Kremer, C., Hammami, N., Cornelissen, L., Theeten, H., Braeye, T., Torneri, A., Abrams, S., & Hens, N. (2026) "Informing quarantine policy for measles control in primary school and daycare settings: insights from a simulation study, Flanders, Belgium." Eurosurveillance. 31(22).

Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity

PLOS ONE · 2026

Infectious diseases · Immunity and vaccination · Statistical methods

Citation for Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity

Braeye, T., Abrams, S., & Hens, N. (2026) "Factors influencing SARS-CoV-2 IgG test sensitivity: A Bayesian analysis of seroconversion and seroreversion by time since infection, test, age and disease severity." PLOS ONE. 21(2), e0328144.

Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020-January 2021, Belgium

Archives of Public Health · 2026

Infectious diseases · Immunity and vaccination

Citation for Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020-January 2021, Belgium

Braeye, T., De Pauw, R., Geebelen, L., Abrams, S., Desombere, I., Hens, N., Hammami, N., Roelants, M., Muylaert, A., & Herzog, S.A. (2026) "Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020-January 2021, Belgium." Archives of Public Health. 84(1).

Decentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?

BMC Infectious Diseases · 2026

Infectious diseases

Citation for Decentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?

Tadesse, D., Henten, S., Batire, S., Woge, M.T., Degaga, T.S., Merdekios, B., Abrams, S., Hailu, A., Geertruyden, J.P.V., Griensven, J., & Pareyn, M. (2026) "Decentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?." BMC Infectious Diseases. 26(1).

Corrigendum to “Beyond staffing ratios - team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis” [Int. J. Nurs. Stud. 181 (2026) 105570]

International journal of nursing studies · 2026

Citation for Corrigendum to “Beyond staffing ratios - team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis” [Int. J. Nurs. Stud. 181 (2026) 105570]

Vleminckx, Senne; De Meulenaere, Kim; Van Bogaert, Peter; ABRAMS, Steven; WILLEM, Lander; Haegdorens, Filip. (2026). Corrigendum to “Beyond staffing ratios - team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis” [Int. J. Nurs. Stud. 181 (2026) 105570]. International journal of nursing studies.

Beyond staffing ratios-team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis

International Journal of Nursing Studies · 2026

Clinical and public health research

Citation for Beyond staffing ratios-team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis

Vleminckx, S., De Meulenaere, K., Van Bogaert, P., Abrams, S., Willem, L., & Haegdorens, F. (2026) "Beyond staffing ratios-team demographic diversity, workforce stability, and their effects on patient safety and workforce sustainability: A multi-country analysis." International Journal of Nursing Studies. 181, 105570.

A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned

Archives of public health · 2026

Citation for A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned

BAGAFORO, Roel Jude; DUPAS, Marie-Cécile; ABRAMS, Steven; Dellicour, Simon; HENS, Niel. (2026). A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned. Archives of public health.

Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo

Vaccine · 2025

Immunity and vaccination

Citation for Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo

Garcia-Fogeda, I., Abrams, S., Vanhee, S., Salloum, M., Ogunjimi, B., & Hens, N. (2025) "Within-host mathematical models to study antibody kinetics after the prophylactic Ebola vaccine in the Democratic Republic of the Congo." Vaccine. 64, 127707.

Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study

The Lancet Digital Health · 2025

Immunity and vaccination

Citation for Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study

Gonzalez Dorta, H., Verbeeck, J., Crevecoeur, J., Morales, D.R., Loedy, N., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., Quinten, C., & Abrams, S. (2025) "Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study." The Lancet Digital Health. 7(5), 100861.

Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status

Journal of Medical Virology · 2025

Infectious diseases · Immunity and vaccination

Citation for Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status

Huyghe, E., Abrams, S., André, E., Anseeuw, K., Bernaert, E., Bruynseels, P., Cuypers, L., De Schouwer, P., Hilkens, P., Keyaerts, E., Laenen, L., Maes, J., Magerman, K., Van de gaer, O., Verdonck, A., Verstrepen, W., Ombelet, S., & Naesens, R. (2025) "Systematic Molecular Influenza A/B Screening Upon Hospital Admission in Belgium, January-April 2022: Positivity Ratios and Viral Loads According to Symptomatology, Age, and Vaccination Status." Journal of Medical Virology. 97(1).

Improving the efficiency of drug resistant tuberculosis treatment trials: a time-to-event alternative marker for bacteriological response and adaptive minimization for randomization

BMC Medical Research Methodology · 2025

Infectious diseases · Statistical methods

Citation for Improving the efficiency of drug resistant tuberculosis treatment trials: a time-to-event alternative marker for bacteriological response and adaptive minimization for randomization

De Vos, E., Van Rie, A., & Abrams, S. (2025) "Improving the efficiency of drug resistant tuberculosis treatment trials: a time-to-event alternative marker for bacteriological response and adaptive minimization for randomization." BMC Medical Research Methodology. 25(1).

Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients

Scientific Reports · 2025

Infectious diseases · Immunity and vaccination

Citation for Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients

Debie, Y., Garcia-Fogeda, I., Willem, L., Roelant, E., Verbruggen, L., Vanhoutte, G., Croes, L., Vulsteke, C., Demey, W., Lybaert, W., Hanssens, M., Bols, A., Van ongeval, J., De Becker, A., Jansens, H., Goossens, M.E., Janssens, A., Prenen, H., Anguille, S., Peeters, M., van Dam, P.A., Hens, N., Abrams, S., & Vandamme, T. (2025) "Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients." Scientific Reports. 15(1).

Charcoal and firewood use in urban areas of developing countries: Drivers, consequences, and the need for clean cooking solutions

Renewable and Sustainable Energy Reviews · 2025

Clinical and public health research

Citation for Charcoal and firewood use in urban areas of developing countries: Drivers, consequences, and the need for clean cooking solutions

Balume, B.S., Bijnens, L., Abrams, S., Banza, B.B., & Deferme, W. (2025) "Charcoal and firewood use in urban areas of developing countries: Drivers, consequences, and the need for clean cooking solutions." Renewable and Sustainable Energy Reviews. 217, 115745.

Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis

Nature Communications · 2025

Infectious diseases

Citation for Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis

Angeli, L., Caetano, C.P., Franco, N., Coletti, P., Faes, C., Molenberghs, G., Beutels, P., Abrams, S., Willem, L., & Hens, N. (2025) "Assessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis." Nature Communications. 16(1).

Assessing the capacity of primary healthcare facilities and healthcare workers in managing diabetes and hypertension in Kisumu county, Kenya

BMC Health Services Research · 2025

Clinical and public health research

Citation for Assessing the capacity of primary healthcare facilities and healthcare workers in managing diabetes and hypertension in Kisumu county, Kenya

Ouma, O.J., Omondi, D., Museve, E., Owenga, J., Bogers, J., Abrams, S., & van Olmen, J. (2025) "Assessing the capacity of primary healthcare facilities and healthcare workers in managing diabetes and hypertension in Kisumu county, Kenya." BMC Health Services Research. 25(1).

An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters

Malaria Journal · 2025

Infectious diseases

Citation for An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters

Grosso, A., Hens, N., & Abrams, S. (2025) "An integrative review of the combined use of mathematical and statistical models for estimating malaria transmission parameters." Malaria Journal. 24(1).

An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union

European Journal of Public Health · 2025

Immunity and vaccination

Citation for An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union

Loedy, N., Dorta, H.G., Abrams, S., Crèvecoeur, J., Morales, D.R., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., Quinten, C., & Verbeeck, J. (2025) "An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union." European Journal of Public Health. 35(5), 1007–1013.

Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium

Journal of Theoretical Biology · 2024

Infectious diseases

Citation for Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium

Angeli, L., Caetano, C.P., Franco, N., Abrams, S., Coletti, P., Van Nieuwenhuyse, I., Pop, S., & Hens, N. (2024) "Who acquires infection from whom? A sensitivity analysis of transmission dynamics during the early phase of the COVID-19 pandemic in Belgium." Journal of Theoretical Biology. 581, 111721.

Types and Effectiveness of Community-Based Cardiovascular Disease Preventive Interventions in Reducing Alcohol Consumption: A Systematic Review and Meta-Analysis

Cureus Journal of Medical Science · 2024

Clinical and public health research

Citation for Types and Effectiveness of Community-Based Cardiovascular Disease Preventive Interventions in Reducing Alcohol Consumption: A Systematic Review and Meta-Analysis

Berhe, N.M., Hassen, H.Y., Van Geertruyden, J.P., Ndejjo, R., Musinguzi, G., Bastiaens, H., & Abrams, S. (2024) "Types and Effectiveness of Community-Based Cardiovascular Disease Preventive Interventions in Reducing Alcohol Consumption: A Systematic Review and Meta-Analysis." Cureus Journal of Medical Science.

The Intestinal Mucin Isoform Landscape Reveals Region- Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification

Journal of Crohn's and colitis · 2024

Clinical and public health research

Citation for The Intestinal Mucin Isoform Landscape Reveals Region- Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification

Arras, W., Breugelmans, T., Oosterlinck, B., De Man, J.G., Malhotra-Kumar, S., Abrams, S., Van Laere, S., Macken, E., Somers, M., Jauregui-Amezaga, A., De Winter, B.Y., & Smet, A. (2024) "The Intestinal Mucin Isoform Landscape Reveals Region- Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification." Journal of Crohn's and Colitis. 19(3).

The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)

BMC Public Health · 2024

Infectious diseases · Immunity and vaccination

Citation for The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)

Willem, L., Abrams, S., Franco, N., Coletti, P., Libin, P.J.K., Wambua, J., Couvreur, S., André, E., Wenseleers, T., Mao, Z., Torneri, A., Faes, C., Beutels, P., & Hens, N. (2024) "The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)." BMC Public Health. 24(1).

Predictors of moderate-to-severe side-effects following COVID-19 mRNA booster vaccination: a prospective cohort study among primary health care providers in Belgium

BMC Infectious Diseases · 2024

Infectious diseases · Immunity and vaccination

Citation for Predictors of moderate-to-severe side-effects following COVID-19 mRNA booster vaccination: a prospective cohort study among primary health care providers in Belgium

Domen, J., Abrams, S., Digregorio, M., Van Ngoc, P., Duysburgh, E., Scholtes, B., & Coenen, S. (2024) "Predictors of moderate-to-severe side-effects following COVID-19 mRNA booster vaccination: a prospective cohort study among primary health care providers in Belgium." BMC Infectious Diseases. 24(1).

Exploring the Pareto front of multi-objective COVID-19 mitigation policies using reinforcement learning

Expert Systems With Applications · 2024

Infectious diseases

Citation for Exploring the Pareto front of multi-objective COVID-19 mitigation policies using reinforcement learning

Reymond, M., Hayes, C.F., Willem, L., Rădulescu, R., Abrams, S., Roijers, D.M., Howley, E., Mannion, P., Hens, N., Nowé, A., & Libin, P. (2024) "Exploring the Pareto front of multi-objective COVID-19 mitigation policies using reinforcement learning." Expert Systems With Applications. 249, 123686.

Characterising information gains and losses when collecting multiple epidemic model outputs

Epidemics · 2024

Infectious diseases

Citation for Characterising information gains and losses when collecting multiple epidemic model outputs

Sherratt, K., Srivastava, A., Ainslie, K., Singh, D.E., Cublier, A., Marinescu, M.C., Carretero, J., Garcia, A.C., Franco, N., Willem, L., Abrams, S., Faes, C., Beutels, P., Hens, N., Müller, S., Charlton, B., Ewert, R., Paltra, S., Rakow, C., Rehmann, J., Conrad, T., Schütte, C., Nagel, K., Abbott, S., Grah, R., Niehus, R., Prasse, B., Sandmann, F., & Funk, S. (2024) "Characterising information gains and losses when collecting multiple epidemic model outputs." Epidemics. 47, 100765.

Bernstein-based estimation of the cross ratio function

Statistics · 2024

Statistical methods

Citation for Bernstein-based estimation of the cross ratio function

Abrams, S., Sercik, Ö., & Veraverbeke, N. (2024) "Bernstein-based estimation of the cross ratio function." Statistics. 58(1), 230–246.

Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review

Vaccine · 2023

Infectious diseases · Immunity and vaccination

Citation for Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review

Garcia-Fogeda, I., Besbassi, H., Larivière, Y., Ogunjimi, B., Abrams, S., & Hens, N. (2023) "Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination: A systematic review." Vaccine. 41(25), 3701–3709.

The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021

BMC Infectious Diseases · 2023

Infectious diseases

Citation for The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021

Nguyen, M.H., Nguyen, T.H.T., Molenberghs, G., Abrams, S., Hens, N., & Faes, C. (2023) "The impact of national and international travel on spatio-temporal transmission of SARS-CoV-2 in Belgium in 2021." BMC Infectious Diseases. 23(1).

The direct disease burden of COVID-19 in Belgium in 2020 and 2021

BMC Public Health · 2023

Infectious diseases

Citation for The direct disease burden of COVID-19 in Belgium in 2020 and 2021

Devleesschauwer, B., Willem, L., Jurčević, J., Smith, P., Scohy, A., Wyper, G.M.A., Pires, S.M., Van Goethem, N., Beutels, P., Franco, N., Abrams, S., Van Cauteren, D., Speybroeck, N., Hens, N., & De Pauw, R. (2023) "The direct disease burden of COVID-19 in Belgium in 2020 and 2021." BMC Public Health. 23(1).

Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies

Frontiers in Immunology · 2023

Immunity and vaccination

Citation for Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies

Besbassi, H., Garcia-Fogeda, I., Quinlivan, M., Breuer, J., Abrams, S., Hens, N., Ogunjimi, B., & Beutels, P. (2023) "Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies." Frontiers in Immunology. 14.

Evolution of human papilloma virus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010-2019)

European Journal of Cancer Prevention · 2023

Immunity and vaccination

Citation for Evolution of human papilloma virus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010-2019)

Huyghe, E., Abrams, S., Bogers, J.P., Verhoeven, V., & Benoy, I. (2023) "Evolution of human papilloma virus prevalence in a highly vaccinated region in Belgium: a retrospective cohort study in Flemish women (2010-2019)." European Journal of Cancer Prevention. 32(1), 48–56.

Disparities in the non-laboratory INTERHEART risk score and its components in selected countries of Europe and sub-Saharan Africa: analysis from the SPICES multi-country project

European Heart Journal · 2023

Clinical and public health research

Citation for Disparities in the non-laboratory INTERHEART risk score and its components in selected countries of Europe and sub-Saharan Africa: analysis from the SPICES multi-country project

Hassen, H.Y., Abrams, S., Musinguzi, G., Rogers, I., Dusabimana, A., Mphekgwana, P.M., Bastiaens, H., Bastiaens, H., Hassen, H.Y., Aerts, N., Anthierens, S., Van Royen, K., Masquillier, C., Le Reste, J.Y., Le Goff, D., Perraud, G., van Marwijk, H., Ford, E., Grice-Jackson, T., Rogers, I., Nahar, P., Gibson, L., Bowyer, M., Nkengateh, A., Musinguzi, G., Ndejjo, R., Nuwaha, F., Sodi, T., Mphekgwana, P.M., Malema, N., Kgatla, N., & Mothiba, T.M. (2023) "Disparities in the non-laboratory INTERHEART risk score and its components in selected countries of Europe and sub-Saharan Africa: analysis from the SPICES multi-country project." European Heart Journal. 3(6).

Dietary outcomes of community-based cardiovascular disease preventive interventions: a systematic review and meta-analysis

Public Health Nutrition · 2023

Clinical and public health research

Citation for Dietary outcomes of community-based cardiovascular disease preventive interventions: a systematic review and meta-analysis

Hassen, H.Y., Sisay, B.G., Van Geertruyden, J.P., Le Goff, D., Ndejjo, R., Musinguzi, G., Abrams, S., & Bastiaens, H. (2023) "Dietary outcomes of community-based cardiovascular disease preventive interventions: a systematic review and meta-analysis." Public Health Nutrition. 26(11), 2480–2491.

A digital toolkit to contextualize and visualize the benefit and risk of COVID-19 vaccines in the European union

Pharmacoepidemiology and Drug Safety · 2023

Infectious diseases · Immunity and vaccination

Citation for A digital toolkit to contextualize and visualize the benefit and risk of COVID-19 vaccines in the European union

(2023) "A digital toolkit to contextualize and visualize the benefit and risk of COVID-19 vaccines in the European union." Pharmacoepidemiology and Drug Safety. 32(S1), 3–612.

Type and effectiveness of community-based interventions in improving knowledge related to cardiovascular diseases and risk factors: A systematic review

American Journal of Preventive Cardiology · 2022

Clinical and public health research

Citation for Type and effectiveness of community-based interventions in improving knowledge related to cardiovascular diseases and risk factors: A systematic review

Hassen, H.Y., Ndejjo, R., Van Geertruyden, J.P., Musinguzi, G., Abrams, S., & Bastiaens, H. (2022) "Type and effectiveness of community-based interventions in improving knowledge related to cardiovascular diseases and risk factors: A systematic review." American Journal of Preventive Cardiology. 10, 100341.

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult

Frontiers in Pharmacology · 2022

Clinical and public health research

Citation for The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult

Ceuleers, H., Hanning, N., De bruyn, M., De Man, J.G., De Schepper, H.U., Li, Q., Liu, L., Abrams, S., Smet, A., Joossens, J., Augustyns, K., De Meester, I., Pasricha, P.J., & De Winter, B.Y. (2022) "The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult." Frontiers in Pharmacology. 13.

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

Pathogens · 2022

Infectious diseases

Citation for Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

Dusabimana, A., Siewe Fodjo, J.N., Ndahura, M.M., Mmbando, B.P., Jada, S.R., Boven, A., De Smet, E., Ukety, T., Njamnshi, A.K., Laudisoit, A., Abrams, S., & Colebunders, R. (2022) "Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening." Pathogens. 11(3), 281.

Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020

Eurosurveillance · 2022

Infectious diseases · Immunity and vaccination

Citation for Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020

Herzog, S.A., De Bie, J., Abrams, S., Wouters, I., Ekinci, E., Patteet, L., Coppens, A., De Spiegeleer, S., Beutels, P., Van Damme, P., Hens, N., & Theeten, H. (2022) "Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020." Eurosurveillance. 27(9).

Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis

Nephrology Dialysis Transplantation · 2022

Immunity and vaccination

Citation for Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis

Verleye, A., Wijtvliet, V., Abrams, S., Hellemans, R., Bougrea, R., Massart, A., Pipeleers, L., Wissing, K.M., Ariën, K.K., De Winter, B.Y., Van Damme, P., Abramowicz, D., & Ledeganck, K.J. (2022) "Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis." Nephrology Dialysis Transplantation. 37(8), 1566–1575.

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

Trials · 2022

Infectious diseases

Citation for Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

Van Rie, A., De Vos, E., Costa, E., Verboven, L., Ndebele, F., Heupink, T.H., Abrams, S., Maraba, N., Makkan, H., Beattie, T., Sibeko, Z.R., Bohlela, S., Segwaba, P., Ogunbayo, E.A., Mhlambi, N., Wells, F., Rigouts, L., Maartens, G., Conradie, F., Black, J., Potgieter, S., Fanampe, B., Van der Spoel Van Dyk, A., Charalambous, S., Churchyard, G., & Warren, R. (2022) "Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial." Trials. 23(1).

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies

Transplant Immunology · 2022

Infectious diseases · Immunity and vaccination

Citation for SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies

Wijtvliet, V.P.W.M., Verheyden, S., Depreter, B., Heylen, C., Coeman, E., Abrams, S., De Winter, B.Y., Massart, A., Hellemans, R., Pipeleers, L., Claas, F.H.J., Ariën, K.K., Wissing, K.M., Abramowicz, D., & Ledeganck, K.J. (2022) "SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies." Transplant Immunology. 74, 101670.

Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study

Journal of Infection and Chemotherapy · 2022

Infectious diseases

Citation for Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study

Tran, T.N., Vu, D.H., Nguyen, H.A., Abrams, S., Bruyndonckx, R., Nguyen, T.T., Tran, N.M., Trinh, T.A., Do, T.H.G., Pham, H.N., Nguyen, G.B., & Coenen, S. (2022) "Predicting mortality in intensive care unit patients infected with Klebsiella pneumoniae: A retrospective cohort study." Journal of Infection and Chemotherapy. 28(1), 10–18.

Nonparametric estimation of risk ratios for bivariate data

Journal of Nonparametric Statistics · 2022

Statistical methods

Citation for Nonparametric estimation of risk ratios for bivariate data

Abrams, S., Janssen, P., Swanepoel, J., & Veraverbeke, N. (2022) "Nonparametric estimation of risk ratios for bivariate data." Journal of Nonparametric Statistics. 34(4), 940–963.

Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice

JAC-Antimicrobial Resistance · 2022

Clinical and public health research

Citation for Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice

D’Hulster, L., Abrams, S., Bruyndonckx, R., Anthierens, S., Adriaenssens, N., Butler, C.C., Verheij, T., Goossens, H., Little, P., & Coenen, S. (2022) "Nationwide implementation of online communication skills training to reduce overprescribing of antibiotics: a stepped-wedge cluster randomized trial in general practice." JAC-Antimicrobial Resistance. 4(3).

mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

Nephrology Dialysis Transplantation · 2022

Immunity and vaccination

Citation for mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

Wijtvliet, V.P.W.M., Ariën, K.K., Abrams, S., Couttenye, M.M., Mestrez, F., Mariën, J., De Winter, B.Y., Van Damme, P., Pipeleers, L., Wissing, K.M., Abramowicz, D., & Ledeganck, K.J. (2022) "mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?." Nephrology Dialysis Transplantation. 37(4), 799–803.

Modelling longitudinal binary outcomes with outcome dependent observation times: an application to a malaria cohort study

Malaria Journal · 2022

Infectious diseases · Statistical methods

Citation for Modelling longitudinal binary outcomes with outcome dependent observation times: an application to a malaria cohort study

Martins, A., Herzog, S.A., Mugenyi, L., Faes, C., Hens, N., & Abrams, S. (2022) "Modelling longitudinal binary outcomes with outcome dependent observation times: an application to a malaria cohort study." Malaria Journal. 21(1).

Level of cardiovascular disease knowledge, risk perception and intention towards healthy lifestyle and socioeconomic disparities among adults in vulnerable communities of Belgium and England

BMC Public Health · 2022

Clinical and public health research

Citation for Level of cardiovascular disease knowledge, risk perception and intention towards healthy lifestyle and socioeconomic disparities among adults in vulnerable communities of Belgium and England

Hassen, H.Y., Bowyer, M., Gibson, L., Abrams, S., & Bastiaens, H. (2022) "Level of cardiovascular disease knowledge, risk perception and intention towards healthy lifestyle and socioeconomic disparities among adults in vulnerable communities of Belgium and England." BMC Public Health. 22(1).

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

PLOS Computational Biology · 2022

Infectious diseases

Citation for Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

Franco, N., Coletti, P., Willem, L., Angeli, L., Lajot, A., Abrams, S., Beutels, P., Faes, C., & Hens, N. (2022) "Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data." PLOS Computational Biology. 18(3), e1009965.

Identifying immunity gaps for measles using Belgian serial serology data

Vaccine · 2022

Infectious diseases · Immunity and vaccination

Citation for Identifying immunity gaps for measles using Belgian serial serology data

Schenk, J., Abrams, S., Litzroth, A., Cornelissen, L., Grammens, T., Theeten, H., & Hens, N. (2022) "Identifying immunity gaps for measles using Belgian serial serology data." Vaccine. 40(26), 3676–3683.

Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial

Breast Cancer Research and Treatment · 2022

Clinical and public health research

Citation for Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial

Braal, C.L., Westenberg, J.D., Buijs, S.M., Abrams, S., Mulder, T.A.M., van Schaik, R.H.N., Koolen, S.L.W., Jager, A., & Mathijssen, R.H.J. (2022) "Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial." Breast Cancer Research and Treatment. 195(1), 65–74.

Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2

PLOS Computational Biology · 2022

Infectious diseases · Statistical methods

Citation for Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2

Kuylen, E.J., Torneri, A., Willem, L., Libin, P.J.K., Abrams, S., Coletti, P., Franco, N., Verelst, F., Beutels, P., Liesenborgs, J., & Hens, N. (2022) "Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2." PLOS Computational Biology. 18(8), e1009980.

COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020

Eurosurveillance · 2022

Infectious diseases

Citation for COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020

Molenberghs, G., Faes, C., Verbeeck, J., Deboosere, P., Abrams, S., Willem, L., Aerts, J., Theeten, H., Devleesschauwer, B., Bustos Sierra, N., Renard, F., Herzog, S., Lusyne, P., Van der Heyden, J., Van Oyen, H., Van Damme, P., & Hens, N. (2022) "COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020." Eurosurveillance. 27(7).

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11 , 281

Pathogens · 2022

Infectious diseases

Citation for Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11 , 281

Dusabimana, A., Siewe Fodjo, J.N., Ndahura, M.M., Mmbando, B.P., Jada, S.R., Boven, A., De Smet, E., Ukety, T., Njamnshi, A.K., Laudisoit, A., Abrams, S., & Colebunders, R. (2022) "Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11 , 281." Pathogens. 11(7), 746.

Validation of the Dutch-Flemish translated ABCD questionnaire to measure cardiovascular diseases knowledge and risk perception among adults

Scientific Reports · 2021

Clinical and public health research

Citation for Validation of the Dutch-Flemish translated ABCD questionnaire to measure cardiovascular diseases knowledge and risk perception among adults

Hassen, H.Y., Aerts, N., Demarest, S., Manzar, M.D., Abrams, S., & Bastiaens, H. (2021) "Validation of the Dutch-Flemish translated ABCD questionnaire to measure cardiovascular diseases knowledge and risk perception among adults." Scientific Reports. 11(1).

The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19

Nature Communications · 2021

Infectious diseases

Citation for The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19

Willem, L., Abrams, S., Libin, P.J.K., Coletti, P., Kuylen, E., Petrof, O., Møgelmose, S., Wambua, J., Herzog, S.A., Faes, C., Beutels, P., & Hens, N. (2021) "The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19." Nature Communications. 12(1).

Quantiles of the conditional residual lifetime

Statistics · 2021

Statistical methods

Citation for Quantiles of the conditional residual lifetime

Abrams, S., Janssen, P., & Veraverbeke, N. (2021) "Quantiles of the conditional residual lifetime." Statistics. 55(6), 1271–1290.

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

Epidemics · 2021

Infectious diseases

Citation for Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories

Abrams, S., Wambua, J., Santermans, E., Willem, L., Kuylen, E., Coletti, P., Libin, P., Faes, C., Petrof, O., Herzog, S.A., Beutels, P., & Hens, N. (2021) "Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories." Epidemics. 35, 100449.

Measuring association among censored antibody titer data

Statistics in Medicine · 2021

Immunity and vaccination · Statistical methods

Citation for Measuring association among censored antibody titer data

Tran, T.M.P., Abrams, S., Aerts, M., Maertens, K., & Hens, N. (2021) "Measuring association among censored antibody titer data." Statistics in Medicine. 40(16), 3740–3761.

Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis

The Lancet Infectious Diseases · 2021

Infectious diseases · Immunity and vaccination

Citation for Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis

Schenk, J., Abrams, S., Theeten, H., Van Damme, P., Beutels, P., & Hens, N. (2021) "Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis." The Lancet Infectious Diseases. 21(2), 286–295.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

PLOS ONE · 2021

Infectious diseases

Citation for Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

Heireman, L., Abrams, S., Bruynseels, P., Cartuyvels, R., Cuypers, L., De Schouwer, P., Laffut, W., Lagrou, K., Hens, N., Ho, E., Padalko, E., Reynders, M., Vandamme, S., Van der Moeren, N., Verstrepen, W., Willems, P., & Naesens, R. (2021) "Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium." PLOS ONE. 16(11), e0259908.

Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy

PLOS ONE · 2021

Clinical and public health research

Citation for Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy

Geens, M., Stappers, S., Konings, H., De Winter, B.Y., Specenier, P., Van Meerbeeck, J.P., Verpooten, G.A., Abrams, S., Janssens, A., Peeters, M., Van de Heyning, P., Vanderveken, O.M., & Ledeganck, K.J. (2021) "Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy." PLOS ONE. 16(6), e0252646.

Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression

Preventive Medicine · 2021

Clinical and public health research

Citation for Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression

Hassen, H.Y., Ndejjo, R., Musinguzi, G., Van Geertruyden, J.P., Abrams, S., & Bastiaens, H. (2021) "Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: A systematic review and meta-regression." Preventive Medicine. 153, 106797.

Community-Based Interventions for Cardiovascular Disease Prevention in Low-and Middle-Income Countries: A Systematic Review

Public Health Reviews · 2021

Clinical and public health research

Citation for Community-Based Interventions for Cardiovascular Disease Prevention in Low-and Middle-Income Countries: A Systematic Review

Ndejjo, R., Hassen, H.Y., Wanyenze, R.K., Musoke, D., Nuwaha, F., Abrams, S., Bastiaens, H., & Musinguzi, G. (2021) "Community-Based Interventions for Cardiovascular Disease Prevention in Low-and Middle-Income Countries: A Systematic Review." Public Health Reviews. 42.

A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies

BMC Infectious Diseases · 2021

Infectious diseases

Citation for A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies

Coletti, P., Libin, P., Petrof, O., Willem, L., Abrams, S., Herzog, S.A., Faes, C., Kuylen, E., Wambua, J., Beutels, P., & Hens, N. (2021) "A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies." BMC Infectious Diseases. 21(1).

Urinary N-acetyltyramine-O,β-glucuronide in persons with onchocerciasis-associated epilepsy

Pathogens · 2020

Infectious diseases

Citation for Urinary N-acetyltyramine-O,β-glucuronide in persons with onchocerciasis-associated epilepsy

Hotterbeekx, A., Dusabimana, A., Mandro, M., Abhafule, G.M., Deogratias, W.R., Siewe Fodjo, J.N., Abrams, S., & Colebunders, R. (2020) "Urinary N-acetyltyramine-O,β-glucuronide in persons with onchocerciasis-associated epilepsy." Pathogens. 9(3), 191.

Trends and determinants of health facility childbirth service utilization among mothers in urban slums of Nairobi, Kenya

Global Epidemiology · 2020

Clinical and public health research

Citation for Trends and determinants of health facility childbirth service utilization among mothers in urban slums of Nairobi, Kenya

Atahigwa, C., Kadengye, D.T., Iddi, S., Abrams, S., & Van Rie, A. (2020) "Trends and determinants of health facility childbirth service utilization among mothers in urban slums of Nairobi, Kenya." Global Epidemiology. 2, 100029.

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

International Journal of Environmental Research and Public Health · 2020

Infectious diseases

Citation for Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Faes, C., Abrams, S., Van Beckhoven, D., Meyfroidt, G., Vlieghe, E., & Hens, N. (2020) "Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients." International Journal of Environmental Research and Public Health. 17(20), 7560.

The potential of donor-derived cell-free DNA as a biomarker for rejection in kidney transplantation: A systematic review and meta-analysis

Nephrology Dialysis Transplantation · 2020

Clinical and public health research

Citation for The potential of donor-derived cell-free DNA as a biomarker for rejection in kidney transplantation: A systematic review and meta-analysis

Wijtvliet, V., Plaeke, P., Abrams, S., Hens, N., Gielis, E., Hellemans, R., De Winter, B., Abramowicz, D., & Ledeganck, K. (2020) "The potential of donor-derived cell-free DNA as a biomarker for rejection in kidney transplantation: A systematic review and meta-analysis." Nephrology Dialysis Transplantation. 35(Supplement_3): 190.

Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study

PLOS ONE · 2020

Clinical and public health research

Citation for Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study

Hassen, H.Y., Bastiaens, H., Van Royen, K., & Abrams, S. (2020) "Socioeconomic and behavioral determinants of cardiovascular diseases among older adults in Belgium and France: A longitudinal analysis from the SHARE study." PLOS ONE. 15(12), e0243422.

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo

Pathogens · 2020

Infectious diseases

Citation for Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo

Mandro, M., Siewe Fodjo, J.N., Dusabimana, A., Mukendi, D., Haesendonckx, S., Lokonda, R., Nakato, S., Nyisi, F., Abhafule, G., Wonya’rossi, D., Hotterbeekx, A., Abrams, S., & Colebunders, R. (2020) "Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo." Pathogens. 9(3), 205.

Nonparametric estimation of the cross ratio function

Annals of the Institute of Statistical Mathematics · 2020

Statistical methods

Citation for Nonparametric estimation of the cross ratio function

Abrams, S., Janssen, P., Swanepoel, J., & Veraverbeke, N. (2020) "Nonparametric estimation of the cross ratio function." Annals of the Institute of Statistical Mathematics. 72(3), 771–801.

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study

Pathogens · 2020

Infectious diseases

Citation for Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study

Dusabimana, A., Bhwana, D., Raimon, S., Mmbando, B.P., Hotterbeekx, A., Tepage, F., Mandro, M., Siewe Fodjo, J.N., Abrams, S., & Colebunders, R. (2020) "Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study." Pathogens. 9(8), 617.

Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country

Contemporary Clinical Trials · 2020

Infectious diseases

Citation for Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country

Molenberghs, G., Buyse, M., Abrams, S., Hens, N., Beutels, P., Faes, C., Verbeke, G., Van Damme, P., Goossens, H., Neyens, T., Herzog, S., Theeten, H., Pepermans, K., Abad, A.A., Van Keilegom, I., Speybroeck, N., Legrand, C., De Buyser, S., & Hulstaert, F. (2020) "Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country." Contemporary Clinical Trials. 99, 106189.

Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: A retrospective case-control study

Journal of Antimicrobial Chemotherapy · 2020

Infectious diseases

Citation for Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: A retrospective case-control study

Chaname Pinedo, L.E., Bruyndonckx, R., Catry, B., Latour, K., Goossens, H., Abrams, S., & Coenen, S. (2020) "Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: A retrospective case-control study." Journal of Antimicrobial Chemotherapy. 75(7), 1985–1992.

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus

Pathogens · 2020

Infectious diseases

Citation for Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus

Dusabimana, A., Tsebeni Wafula, S., Raimon, S.J., Fodjo, J.N.S., Bhwana, D., Tepage, F., Abd-Elfarag, G., Hotterbeekx, A., Abrams, S., & Colebunders, R. (2020) "Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus." Pathogens. 10(1), 21.

Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis

Transplant International · 2020

Clinical and public health research

Citation for Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis

Wijtvliet, V.P.W.M., Plaeke, P., Abrams, S., Hens, N., Gielis, E.M., Hellemans, R., Massart, A., Hesselink, D.A., De Winter, B.Y., Abramowicz, D., & Ledeganck, K.J. (2020) "Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis." Transplant International. 33(12), 1626–1642.

Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo

Pathogens · 2020

Infectious diseases

Citation for Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo

Hotterbeekx, A., Perneel, J., Mandro, M., Abhafule, G., Siewe Fodjo, J.N., Dusabimana, A., Abrams, S., Kumar-Singh, S., & Colebunders, R. (2020) "Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo." Pathogens. 9(6), 435.

A general frailty model to accommodate individual heterogeneity in the acquisition of multiple infections: An application to bivariate current status data

Statistics in Medicine · 2020

Infectious diseases · Statistical methods

Citation for A general frailty model to accommodate individual heterogeneity in the acquisition of multiple infections: An application to bivariate current status data

Tran, T.M.P., Abrams, S., & Braekers, R. (2020) "A general frailty model to accommodate individual heterogeneity in the acquisition of multiple infections: An application to bivariate current status data." Statistics in Medicine. 39(12), 1695–1714.

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: A comparative analysis with hepatitis a virus seroprevalence

Epidemiology and Infection · 2019

Infectious diseases · Immunity and vaccination

Citation for The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: A comparative analysis with hepatitis a virus seroprevalence

Smit, G.S.A., Abrams, S., Dorny, P., Speybroeck, N., Devleesschauwer, B., Hutse, V., Jansens, H., Theeten, H., Beutels, P., & Hens, N. (2019) "The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: A comparative analysis with hepatitis a virus seroprevalence." Epidemiology and Infection. 147.

The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation

Journal of Theoretical Biology · 2019

Infectious diseases

Citation for The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation

Hendrickx, D.M., Abrams, S., & Hens, N. (2019) "The impact of behavioral interventions on co-infection dynamics: An exploration of the effects of home isolation." Journal of Theoretical Biology. 476, 5–18.

Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling

BMC Medical Research Methodology · 2019

Infectious diseases · Immunity and vaccination · Statistical methods

Citation for Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling

Blaizot, S., Herzog, S.A., Abrams, S., Theeten, H., Litzroth, A., & Hens, N. (2019) "Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling." BMC Medical Research Methodology. 19(1).

Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia

The Journal of Infectious Diseases · 2019

Infectious diseases

Citation for Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia

Bannister-Tyrrell, M., Krit, M., Sluydts, V., Tho, S., Sokny, M., Mean, V., Kim, S., Menard, D., Grietens, K.P., Abrams, S., Hens, N., Coosemans, M., Bassat, Q., van Hensbroek, M.B., Durnez, L., & Van Bortel, W. (2019) "Households or Hotspots? Defining Intervention Targets for Malaria Elimination in Ratanakiri Province, Eastern Cambodia." The Journal of Infectious Diseases. 220(6), 1034–1043.

Correlated gamma frailty models for bivariate survival time data

Statistical Methods in Medical Research · 2019

Statistical methods

Citation for Correlated gamma frailty models for bivariate survival time data

Martins, A., Aerts, M., Hens, N., Wienke, A., & Abrams, S. (2019) "Correlated gamma frailty models for bivariate survival time data." Statistical Methods in Medical Research. 28(10-11), 3437–3450.

Parametric overdispersed frailty models for current status data

Biometrics · 2017

Statistical methods

Citation for Parametric overdispersed frailty models for current status data

Abrams, S., Aerts, M., Molenberghs, G., & Hens, N. (2017) "Parametric overdispersed frailty models for current status data." Biometrics. 73(4), 1388–1400.

Modelling time varying heterogeneity in recurrent infection processes: an application to serological data

Journal of the Royal Statistical Society: Series C (Applied Statistics) · 2017

Infectious diseases · Immunity and vaccination · Statistical methods

Citation for Modelling time varying heterogeneity in recurrent infection processes: an application to serological data

Abrams, S., Wienke, A., & Hens, N. (2017) "Modelling time varying heterogeneity in recurrent infection processes: an application to serological data." Journal of the Royal Statistical Society: Series C (Applied Statistics). 67(3), 687–704.

Inferring rubella outbreak risk from seroprevalence data in Belgium

Vaccine · 2016

Infectious diseases · Immunity and vaccination

Citation for Inferring rubella outbreak risk from seroprevalence data in Belgium

Abrams, S., Kourkouni, E., Sabbe, M., Beutels, P., & Hens, N. (2016) "Inferring rubella outbreak risk from seroprevalence data in Belgium." Vaccine. 34(50), 6187–6192.

COL 2-03 - Resurgence risk for measles, mumps and rubella in France in 2016

Medecine et Maladies Infectieuses · 2016

Infectious diseases

Citation for COL 2-03 - Resurgence risk for measles, mumps and rubella in France in 2016

Béraud, G., Abrams, S., Levy-Bruhl, D., Antona, D., Beutels, P., Dervaux, B., & Hens, N. (2016) "COL 2-03 - Resurgence risk for measles, mumps and rubella in France in 2016." Medecine et Maladies Infectieuses. 46(4), 4.

Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013

Eurosurveillance · 2015

Infectious diseases · Immunity and vaccination

Citation for Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013

Hens, N., Abrams, S., Santermans, E., Theeten, H., Goeyvaerts, N., Lernout, T., Leuridan, E., Van Kerckhove, K., Goossens, H., Van Damme, P., & Beutels, P. (2015) "Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013." Eurosurveillance. 20(1).